Brief: Finvector Vision Therapies initiates arbitration proceedings against Herantis Pharma unit
09/03/2015 10:00
March 9 (Reuters) - Herantis Pharma Oyj HRTIS.HE :
* Finvector Vision Therapies has initiated arbitration proceedings against Herantis Pharma's
subsidiary Laurantis Pharma and a number of its former shareholders
* Finvector is seeking from Laurantis and a number of its former shareholders damages in
total amount of about 1,000,000 euros ($1.09 million) including interests and costs
* Says as Herantis understands it, there has been no breach of the shareholders' agreement
and the claim presented by Finvector is unfounded
Source text for Eikon: ID:nHUGjSgFD
Further company coverage: HRTIS.HE
($1 = 0.9183 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))